ConductScience.org, home

Trial · NCT06620562

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryWeight lossbaseline to 24 months% Excess weight loss
PrimaryPercentage of participant with an Excess Weight Loss above 50%Baseline to 24 months
SecondaryResolution of associated comorbiditiesBaseline to 24 monthsType 2 diabetes, hypertension and dislipidemia
SecondaryImprovement of Eating behaviors (Food Craving State Questionnaire)Baseline to 24 monthsEvaluates severity of cravings using a validated questionnaire. Minimum : 15; Maximum : 75; Higher scores mean a worse outcome.
SecondaryImprovement of Eating behaviors (Food Craving Trait Questionnaire)Baseline to 24 monthsEvaluates severity of cravings using a validated questionnaire. Minimum : 39; Maximum : 234; Higher scores mean a worse outcome.
SecondaryDecrease in food explicit and implicit wanting and liking food reward.Baseline to 24 monthDecrease in food explicit and implicit wanting and liking food reward assessed by Leeds Food Preference Questionnaire using a computerized behavioural task
SecondaryImprovement in well-being, mood and Quality of Life (SF-36)Baseline to 24 months36-item short form survey evaluating quality of life on a scale from 0 to 100, higher scores indicate better quality of life
SecondaryImprovement in well-being, mood and Quality of Life (QLaval)Baseline to 24 monthsLaval questionnaire evaluating quality of life on 6 aspects on a scale from 0 to 7, higher scores indicate better quality of life
SecondaryImprovement in well-being, mood and Quality of Life (HAD questionnaire)Baseline to 24 months
HAD questionnaire includes 14 rated items from 0 to 3. Seven questions relate to anxiety (total A) and seven others to the depressive dimension (total D), obtaining two scores (maximum score of each score = 21). Higher scores indicate a worse outcome
SecondaryGastro-intestinal side-effectsBaseline to 24-monthGastro-intestinal side-effects assessed by GIQLI questionnaire on a scale from 0 to 144. Higher scores indicate better quality of life
SecondaryImprovement of Eating behaviors (Binge Eating Scale)Baseline to 24 months
To assess the presence of certain binge eating behaviors that may be indicative of an eating disorder. The higher the score, the more binge eating behaviors is observed. The minimum score is 0 while the maximum score is 46. The final result allows to say if the person has an absent (less than 17), moderate (between 18 and 26) or severe (more than 27) binging level.
SecondaryImprovement of Eating behaviors (YFAS 2.0)Baseline to 24 months
The YFAS 2.0 was designed to assess food addiction. It assesses the symptoms of food addiction and the resulting distress and impaired functioning. The higher the level of symptoms, the more severe the food addiction. Impaired functioning and distress are scored from 0 to 2. Symptoms are scored from 0 to 11. If the functioning and distress score is 1 and above, the food addiction may be mild (2-3 symptoms), moderate (4-5 symptoms), or severe (6+ symptoms).

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06620562/registered